Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Steroid 17-alpha-monooxygenase, encoded by the CYP17A1 gene, is a crucial enzyme in steroid hormone biosynthesis. It catalyzes both 17α-hydroxylation and 17,20-lyase reactions, converting pregnenolone and progesterone into precursors for glucocorticoids and sex hormones. CYP17A1 is primarily expressed in the adrenal cortex and gonadal tissues. Its activity is regulated by cofactors such as cytochrome P450 oxidoreductase and cytochrome b5, as well as phosphorylation. Mutations in CYP17A1 can lead to various disorders, including congenital adrenal hyperplasia and disorders of sexual development. Targeted inhibition of CYP17A1 is used therapeutically in prostate cancer.
Inhibition of steroid 17-alpha-monooxygenase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Steroid 17-alpha-monooxygenase (CYP17).